Exponent Increases Share Repurchase Authorization by $150 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 22 2022
0mins
Should l Buy EXPO?
Source: globenewswire
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EXPO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EXPO
Wall Street analysts forecast EXPO stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 68.120
Low
81.00
Averages
85.50
High
90.00
Current: 68.120
Low
81.00
Averages
85.50
High
90.00
About EXPO
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Exponent Appoints New Executives and Board Changes
- Executive Appointments: Exponent has announced that John Pye will become president and Eric Anderson will take on the role of CFO effective May 1, 2026, marking a significant leadership change aimed at driving future growth and innovation.
- Board Election: Current CFO Richard Schlenker has been nominated for election to the board of directors, reflecting the company's recognition of his financial management capabilities and providing stronger support for future strategic decisions.
- Chairman Transition: Karen Richardson will assume the role of chairman of the board on June 4, 2026, succeeding the retiring Paul Johnston, which may influence the company's governance structure and strategic direction.
- Leadership Experience: John Pye has been with Exponent since 1999, holding multiple senior leadership roles, currently serving as Vice President of Global Offices and Innovation, and his extensive experience will provide crucial support for the company's future development.
See More
Exponent Appoints New Executives to Drive Growth
- Executive Appointments: Exponent has announced the appointment of John Pye as President and Eric Anderson as Chief Financial Officer, both effective May 1, 2026, aimed at enhancing leadership to drive the company's long-term growth strategy.
- Leadership Experience: John Pye, who joined Exponent in 1999 and has held several key positions, demonstrates leadership in technological innovation and complex client challenges, which is expected to propel the company to greater success in a rapidly changing market.
- Financial Management: Eric Anderson, who joined the firm in 2003, brings extensive financial and operational expertise, and his appointment will strengthen Exponent's financial processes, ensuring integrity and transparency in high-standard financial reporting.
- Board Changes: Current Chairman Paul Johnston will retire on June 4, 2026, with Karen Richardson set to succeed him, and Richard Schlenker nominated as a director, reflecting the company's ongoing stability and development in leadership.
See More
EXPO Stock Price Fluctuation and Dividend Dynamics
- Price Range Analysis: EXPO's 52-week low is $63.81 per share, with a high of $87.88, and the last trade at $72.55 indicates price fluctuations within this range, reflecting market caution regarding its future performance.
- Technical Indicator Observation: Currently, EXPO's stock price is above its 200-day moving average, suggesting a potential short-term upward trend that may attract investor interest and enhance market liquidity.
- Dividend Stock Dynamics: EXPO is among nine other dividend stocks that recently crossed above their 200-day moving average, indicating a market preference for high-dividend stocks, which could draw more investors seeking stable returns.
- Market Sentiment Assessment: Although the current stock price is below the 52-week high, market sentiment remains neutral, prompting investors to monitor upcoming earnings reports and market developments to assess EXPO's long-term investment value.
See More
Exponent, Inc. Reports Strong Q4 2025 Earnings with AI-Driven Growth
- Significant Revenue Growth: In Q4 2025, Exponent reported an 8% increase in total revenues to $147.4 million, with net income of $24.8 million and diluted earnings per share of $0.49, reflecting strong demand in user research and risk management sectors.
- Diversified Client Base: CEO Catherine Corrigan highlighted ongoing growth in regulatory and safety consulting for medical devices, particularly in failure analysis for electrification and battery systems, which enhances the company's competitive edge in the market.
- Optimistic Future Outlook: CFO Richard Schlenker projected high single-digit growth in net revenues for Q1 and full year 2026, with EBITDA margins expected to remain between 27.5% and 28.5%, indicating strong confidence in future growth prospects.
- Robust Cash Flow: At year-end 2025, cash and cash equivalents stood at $221.9 million, with $131.7 million generated from operations, and the company distributed $14.9 million in dividends while repurchasing $25.1 million in common stock during the quarter, enhancing shareholder returns.
See More
Exponent Reports Q4 2025 Earnings with Positive Outlook
- Earnings Highlights: Exponent's Q4 2025 GAAP EPS of $0.49 exceeded expectations by $0.02, with revenue of $147.4 million reflecting a 7.7% year-over-year increase, surpassing estimates by $15.41 million, indicating strong market performance.
- Headcount Growth: The company achieved approximately 4% growth in headcount for 2025, with improved utilization rates in Q4 year-over-year, demonstrating Exponent's effective alignment of resources with market demand, thereby enhancing operational efficiency.
- Future Outlook: As Exponent enters 2026, it anticipates high-single-digit revenue growth for Q1, with EBITDA projected to be 27.5% to 28.5% of revenues, reflecting a positive outlook on market opportunities and reinforcing confidence in long-term growth.
- Annual Projections: For the full fiscal year 2026, Exponent expects high-single-digit revenue growth, with EBITDA anticipated to be 27.6% to 28.1% of revenues, further solidifying the company's competitive position and sustainable growth potential.
See More
Exponent Reports Q4 2025 Earnings with Strong Growth Outlook
- Strong Earnings Report: Exponent's Q4 2025 GAAP EPS of $0.49 exceeded expectations by $0.02, with revenue of $147.4 million reflecting a 7.7% year-over-year increase, surpassing estimates by $15.41 million, indicating robust market performance.
- Headcount Growth: The company achieved approximately 4% growth in headcount for 2025, with improved resource utilization in Q4 year-over-year, demonstrating Exponent's effective alignment of resources with market demand, thereby enhancing operational efficiency and competitive positioning.
- Optimistic Future Outlook: As Exponent enters 2026, it anticipates high-single-digit revenue growth for Q1, with EBITDA projected to be 27.5% to 28.5% of revenues before reimbursements, reflecting confidence in market opportunities and sustainable long-term growth.
- Positive Annual Projections: For the full fiscal year 2026, Exponent expects high-single-digit revenue growth and EBITDA margins of 27.6% to 28.1%, indicating continued strong financial performance and growth potential in the upcoming year.
See More
Exponent Appoints New Executives and Board Changes
- Executive Appointments: Exponent has announced that John Pye will become president and Eric Anderson will take on the role of CFO effective May 1, 2026, marking a significant leadership change aimed at driving future growth and innovation.
- Board Election: Current CFO Richard Schlenker has been nominated for election to the board of directors, reflecting the company's recognition of his financial management capabilities and providing stronger support for future strategic decisions.
- Chairman Transition: Karen Richardson will assume the role of chairman of the board on June 4, 2026, succeeding the retiring Paul Johnston, which may influence the company's governance structure and strategic direction.
- Leadership Experience: John Pye has been with Exponent since 1999, holding multiple senior leadership roles, currently serving as Vice President of Global Offices and Innovation, and his extensive experience will provide crucial support for the company's future development.
See More
Exponent Appoints New Executives to Drive Growth
- Executive Appointments: Exponent has announced the appointment of John Pye as President and Eric Anderson as Chief Financial Officer, both effective May 1, 2026, aimed at enhancing leadership to drive the company's long-term growth strategy.
- Leadership Experience: John Pye, who joined Exponent in 1999 and has held several key positions, demonstrates leadership in technological innovation and complex client challenges, which is expected to propel the company to greater success in a rapidly changing market.
- Financial Management: Eric Anderson, who joined the firm in 2003, brings extensive financial and operational expertise, and his appointment will strengthen Exponent's financial processes, ensuring integrity and transparency in high-standard financial reporting.
- Board Changes: Current Chairman Paul Johnston will retire on June 4, 2026, with Karen Richardson set to succeed him, and Richard Schlenker nominated as a director, reflecting the company's ongoing stability and development in leadership.
See More
EXPO Stock Price Fluctuation and Dividend Dynamics
- Price Range Analysis: EXPO's 52-week low is $63.81 per share, with a high of $87.88, and the last trade at $72.55 indicates price fluctuations within this range, reflecting market caution regarding its future performance.
- Technical Indicator Observation: Currently, EXPO's stock price is above its 200-day moving average, suggesting a potential short-term upward trend that may attract investor interest and enhance market liquidity.
- Dividend Stock Dynamics: EXPO is among nine other dividend stocks that recently crossed above their 200-day moving average, indicating a market preference for high-dividend stocks, which could draw more investors seeking stable returns.
- Market Sentiment Assessment: Although the current stock price is below the 52-week high, market sentiment remains neutral, prompting investors to monitor upcoming earnings reports and market developments to assess EXPO's long-term investment value.
See More
Exponent, Inc. Reports Strong Q4 2025 Earnings with AI-Driven Growth
- Significant Revenue Growth: In Q4 2025, Exponent reported an 8% increase in total revenues to $147.4 million, with net income of $24.8 million and diluted earnings per share of $0.49, reflecting strong demand in user research and risk management sectors.
- Diversified Client Base: CEO Catherine Corrigan highlighted ongoing growth in regulatory and safety consulting for medical devices, particularly in failure analysis for electrification and battery systems, which enhances the company's competitive edge in the market.
- Optimistic Future Outlook: CFO Richard Schlenker projected high single-digit growth in net revenues for Q1 and full year 2026, with EBITDA margins expected to remain between 27.5% and 28.5%, indicating strong confidence in future growth prospects.
- Robust Cash Flow: At year-end 2025, cash and cash equivalents stood at $221.9 million, with $131.7 million generated from operations, and the company distributed $14.9 million in dividends while repurchasing $25.1 million in common stock during the quarter, enhancing shareholder returns.
See More
Exponent Reports Q4 2025 Earnings with Positive Outlook
- Earnings Highlights: Exponent's Q4 2025 GAAP EPS of $0.49 exceeded expectations by $0.02, with revenue of $147.4 million reflecting a 7.7% year-over-year increase, surpassing estimates by $15.41 million, indicating strong market performance.
- Headcount Growth: The company achieved approximately 4% growth in headcount for 2025, with improved utilization rates in Q4 year-over-year, demonstrating Exponent's effective alignment of resources with market demand, thereby enhancing operational efficiency.
- Future Outlook: As Exponent enters 2026, it anticipates high-single-digit revenue growth for Q1, with EBITDA projected to be 27.5% to 28.5% of revenues, reflecting a positive outlook on market opportunities and reinforcing confidence in long-term growth.
- Annual Projections: For the full fiscal year 2026, Exponent expects high-single-digit revenue growth, with EBITDA anticipated to be 27.6% to 28.1% of revenues, further solidifying the company's competitive position and sustainable growth potential.
See More
Exponent Reports Q4 2025 Earnings with Strong Growth Outlook
- Strong Earnings Report: Exponent's Q4 2025 GAAP EPS of $0.49 exceeded expectations by $0.02, with revenue of $147.4 million reflecting a 7.7% year-over-year increase, surpassing estimates by $15.41 million, indicating robust market performance.
- Headcount Growth: The company achieved approximately 4% growth in headcount for 2025, with improved resource utilization in Q4 year-over-year, demonstrating Exponent's effective alignment of resources with market demand, thereby enhancing operational efficiency and competitive positioning.
- Optimistic Future Outlook: As Exponent enters 2026, it anticipates high-single-digit revenue growth for Q1, with EBITDA projected to be 27.5% to 28.5% of revenues before reimbursements, reflecting confidence in market opportunities and sustainable long-term growth.
- Positive Annual Projections: For the full fiscal year 2026, Exponent expects high-single-digit revenue growth and EBITDA margins of 27.6% to 28.1%, indicating continued strong financial performance and growth potential in the upcoming year.
See More
